Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2003
06/19/2003US20030114513 Use of isatin derivatives as ion channel activating agents
06/19/2003US20030114509 Prophylactic or therapeutic drug for renal diseases
06/19/2003US20030114497 Pharmaceutical compositions of amlodipine and atorvastatin
06/19/2003US20030114469 Combinations
06/19/2003US20030114465 Substituted imidazole neuropeptide Y Y5 receptor antagonists
06/19/2003US20030114442 Reducing concentration of blood lipoproteins
06/19/2003US20030114439 Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003US20030114418 Analgesics; antiinflammatory and arthritic agents; osteoarthritis; rheumatic diseases; gastrointestinal, nervous system, respiratory disorders; wound healing agents; vision defects; kits
06/19/2003US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/19/2003US20030114382 Angiogenesis inhibition
06/19/2003US20030114357 Antidiabetic agents
06/19/2003US20030113881 D-enzyme compositions and methods of their use
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113810 Detecting modulator of G-protein coupled receptors; antilipotic agents; antidiabetic agents; bradycardial agents; anticoagulants; antisense agents
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113772 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113771 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113393 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
06/19/2003US20030113389 Wherein dose of jojoba product provides simmondsin component in an amount greater than 0.05 gram/day
06/19/2003US20030113366 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/19/2003US20030113361 Palatable arginine compounds and uses thereof for cardiovascular health
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
06/19/2003US20030113323 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity
06/19/2003US20030113315 Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
06/19/2003US20030113310 Enteral administration to a mammal a preparation containing a glucose isomerase enzyme capable of converting ingested carbohydrate or digestion product into more absorbable component while reducing the actual metabolic calories
06/19/2003CA2692325A1 Islet cells from human embryonic stem cells
06/19/2003CA2470114A1 Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-heptanoic acid calcium salt (2:1)
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/19/2003CA2469616A1 Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
06/19/2003CA2469607A1 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003CA2469340A1 Treating muscle wasting with selective androgen receptor modulators
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2469143A1 The use of acyl salicylates as heat shock inducers
06/19/2003CA2469049A1 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003CA2468892A1 Vitamin d analogues
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
06/19/2003CA2465759A1 Method for administering birb 796 bs
06/19/2003CA2461491A1 Methods of screening for antagonists of apm1/gzip
06/18/2003EP1319064A2 Gsk3 polypeptides
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1319005A2 Substituted azepino[4,5-b]indoline derivatives
06/18/2003EP1319004A2 Substituted azepino[4,5-b]indole derivatives
06/18/2003EP1319003A1 Xanthine phosphodiesterase v inhibitors
06/18/2003EP1319001A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318996A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318994A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318993A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/18/2003EP1318983A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318981A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318840A2 PHOSPHATONIN-RELATED GENE AND i METHODS OF USE THEREOF /i
06/18/2003EP1318836A2 Treatment of hyperproliferative diseases
06/18/2003EP1318817A1 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318725A2 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
06/18/2003EP1232247A4 Modulation of signal transduction
06/18/2003EP1171128B1 Combination of n-butyldeoxynojirimycin (nb-dnj) and glycolipid degrading enzymes in therapy
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/18/2003EP1015451B1 Tetrahydro gamma-carbolines
06/18/2003EP0981338B1 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
06/18/2003EP0907631B1 Inorganic ion receptor-active compounds
06/18/2003EP0749423B1 Piperidines and pyrrolidines
06/18/2003CN1425062A Dioxygenases catalyzing asymetric cleavage of beta-carotene
06/18/2003CN1425061A Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
06/18/2003CN1424999A Aminoalcohol derivatives
06/18/2003CN1424918A Remedies for diseases in association with decreasing in bone mass
06/18/2003CN1424870A Nuclear transfer with selected donor cells
06/18/2003CN1424102A Chinese medicine preparation for weight-off and reducing fat
06/18/2003CN1424100A Medicines for treating and preventing diabetes and nephrodystrophy
06/18/2003CN1424063A Oral medicinal composition for treating diabetes
06/18/2003CN1424050A Capsules of rana amurensis ovary
06/18/2003CN1424032A Capsule agent with grape-seed extracts as raw material
06/18/2003CN1424027A Composite amino acid capsule and preparation thereof
06/18/2003CN1111531C Process for preparing 6-0-monoesters of castanospermine
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/18/2003CN1111426C Diabetes treating medicine
06/18/2003CN1111413C Anion exchange resin-containing tablets
06/18/2003CN1111357C Food products having enhanced cocoa polyphenol content and processes for producing same
06/17/2003US6579982 Treating inflammation, cancer
06/17/2003US6579972 An antibody having a specific binding affinity to a polypeptide of given amino acid sequence; can use in treating diabetes, skeletal muscle diseases, Alzheimer's disease, or peripheral neuropathies with an agonist or antagonist
06/17/2003US6579899 Composition for treatment of stress
06/17/2003US6579892 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579885 For therapy of attention deficit disorder, hyperactivity disorder, anxiety, depression, post-traumatic stress disorder, supranuclear palsy, eating disorders, obsessive compulsive disorder, analgesia, nicotine addiction, Parkinsonism
06/17/2003US6579883 Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
06/17/2003US6579879 For therapy of diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic microangiopathy and diabetic macroangiopathy in mammals
06/17/2003US6579874 Substituted azoles
06/17/2003US6579870 5-(1,4-diazepan-1-yl)-2-((3 -fluorophenyl)sulfonyl)phenylamine for example; treatment of diseases or disorders of the central nervous system; modulation of serotonin (5-HT) activity
06/17/2003US6579868 Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes
06/17/2003US6579861 Administering alpha -hydroxy-2-methylene-19-nor-homopregnacalciferol for therapy of psoriasis
06/17/2003US6579711 Lactic acid bacteria species
06/17/2003US6579534 Mixture of soy protein and isoflavone
06/17/2003CA2307553C Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
06/17/2003CA2290973C Encapsulated solution dosage forms of sertraline
1 ... 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 ... 1298